# Sandostatin LAR Depot

NDC: 0078-0811
Generic name: octreotide acetate
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20160722

FDA application: NDA021008

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0811"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0811
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9